Adicet Bio, Inc. Share Price
ACETAdicet Bio, Inc. Stock Performance
Open $7.12 | Prev. Close $7.34 | Circuit Range N/A |
Day Range $7.12 - $7.42 | Year Range $0.45 - $8.83 | Volume 2,341 |
Average Traded $7.31 |
Adicet Bio, Inc. Share Price Chart
About Adicet Bio, Inc.
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. It offers gamma delta T cells engineered with chimeric antigen receptors (CARs) to facilitate durable activity in patients. The company's lead product candidate is ADI-001, an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, which is in Phase I clinical trial for the potential treatment of autoimmune diseases and relapsed/refractory B-cell non-hodgkin's lymphoma. It also develops ADI-270, an armored gamma delta CAR T cell product candidate to treat multiple CD70+ solid tumor and hematological malignancies indications, with renal cell carcinoma. The company was founded in 2014 and is based in Boston, Massachusetts.
Adicet Bio, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
23-Feb-26 | $7.00 | $6.94 | -1.98% |
20-Feb-26 | $7.44 | $7.08 | -4.13% |
19-Feb-26 | $6.97 | $7.38 | +5.20% |
18-Feb-26 | $6.91 | $7.02 | +1.15% |
17-Feb-26 | $6.93 | $6.94 | +1.02% |
13-Feb-26 | $6.85 | $6.87 | +3.00% |
12-Feb-26 | $6.91 | $6.67 | -2.49% |